Hjem › Autoimmune sygdomme › Ohio
Autoimmune sygdomme kliniske forsøg i Ohio
13 studier for Autoimmune sygdomme søger deltagere på steder i Ohio.
Byer i Ohio
Officiel studietekst (engelsk)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT03816345Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Cleveland Clinic Foundation, Cleveland
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 21. sep. 2026 · NCT07513181A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT06722235A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT06948318Abatacept for the Treatment of Giant Cell Arteritis
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 50 og opefter · Alle køn · Opdateret 20. aug. 2026 · NCT04474847A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Cleveland Clinic, Cleveland
RekruttererFase 3
Alder 12 og opefter · Alle køn · Opdateret 6. aug. 2026 · NCT06056297Study of BHV-1300 in Graves' Disease
- Site-110, Canton
RekruttererFase 1
Alder 18 til 65 · Alle køn · Opdateret 31. jul. 2026 · NCT06980649Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1038, Cincinnati
RekruttererFase 3
Alder 18 til 80 · Alle køn · Opdateret 30. jul. 2026 · NCT07039916A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Childrens Hospital Medical Center of Akron, Akron
- Cincinnati Children's Hospital, Cincinnati
- University Hospitals Case Medical Center, Cleveland
- og 3 flere
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 6. jul. 2026 · NCT01351545A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- MetroHealth, Cleveland
RekruttererFase 1
Alder 12 til 70 · Alle køn · Opdateret 22. maj 2026 · NCT06308978A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
- Ohio State University, Columbus
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 25. feb. 2026 · NCT06626919Central Vein Sign in Multiple Sclerosis Extension Study
- Cleveland Clinic Foundation, Cleveland
Rekrutterer
Alder 18 til 65 · Alle køn · Opdateret 20. feb. 2026 · NCT07424027IMPACT - AndHealth Autoimmune Research Registry
- AndHealth, Columbus
RekruttererObservationsstudie
Alder 18 til 70 · Alle køn · Opdateret 29. jun. 2023 · NCT05883371Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.